Reimbursement of Costs for Experimental and New Treatment Methods 

Medicine is constantly evolving, with new treatments and therapies emerging regularly. However, getting these treatments covered by health insurance can be challenging. Most health plans only cover treatments they deem medically proven, leaving patients and doctors in a difficult position when a promising new treatment is labeled as experimental or investigational. 

Appealing Decisions That a Treatment Is Experimental 

When an insurer denies a claim because a treatment is experimental, it is essential to follow the insurer’s appeals process meticulously. The first step is to gather as much information as possible about the denial. Obtain detailed information from the insurer, including how they define experimental and the specific reasons they believe your patient’s treatment falls under this category. 

Once you have this information, you can begin building your case. Prepare a comprehensive argument demonstrating why the treatment should not be considered experimental. It can involve citing journal articles and studies that show the treatment’s safety and efficacy, providing letters from medical professionals detailing their experiences and outcomes with the treatment, and referencing guidelines from professional bodies and approvals from regulatory agencies like the FDA. 

Submitting the appeal requires a detailed letter addressing the insurer’s concerns and presenting your evidence. Typically, there are three opportunities to appeal: the first and second internal reviews by the insurance company and an independent external review if the internal appeals are unsuccessful. If the treatment is urgent, it is advisable to request an expedited review to ensure the appeal is heard faster. 

Seeking Clinical Trials 

For patients who have exhausted standard treatments or have been diagnosed with serious conditions, clinical trials may offer new hope. Doctors play a crucial role in identifying suitable clinical trials for their patients. Physicians often know ongoing trials that may be suitable and can help weigh the pros and cons of participation. 

If a doctor’s assistance is not enough, patients can independently search for clinical trials through online databases. For disease-specific trials, patients can also explore specialized databases, such as the database of the National Cancer Institute for cancer trials. 

When evaluating potential trials, several factors must be considered. It is essential to ensure that the patient meets the specific eligibility criteria of the trial. It includes having the disease or condition being studied, fitting the age requirements, and matching the treatment history outlined in the trial’s criteria. Additionally, understanding the trial’s objectives, locations, and duration is crucial. Some trials may require frequent travel to specific locations, which may not be feasible for all patients. Ensuring the trial’s duration aligns with the patient’s needs and life circumstances is also essential. 

Learning More About a Clinical Trial 

Once a promising clinical trial is identified, further inquiries are necessary to gather detailed information about the trial. The trial coordinator can provide comprehensive information about the trial’s purpose, the treatment being tested, and the procedures involved. It is important to ask specific questions to understand the potential risks and benefits of the treatment being studied compared to existing options. It includes inquiring about the tests the treatment has already undergone, the possible side effects, and the expected outcomes. 

Understanding the financial aspects of participating in a clinical trial is also crucial. It is crucial to determine which costs the trial sponsor will cover, such as the cost of the treatment and any travel expenses. Additionally, it is vital to clarify who will bear the costs if the patient is injured during the trial. Knowing whether the patient will be allowed to continue receiving the treatment after the trial ends if it proves beneficial – is another important consideration. 

What Will Your Insurer Pay? 

Understanding what costs an insurer will cover during a clinical trial is crucial for doctors and patients. Current federal laws often require health plans to cover routine patient care costs associated with approved clinical trials. However, specific conditions must be met for these costs to be covered. The patient must be eligible for the trial, and it must be aimed at treating life-threatening conditions. The trial must be federally approved and should not involve out-of-network care unless covered by the plan. 

Health plans are generally not required to cover research costs, such as additional tests done solely for trial purposes. These costs are often covered by the trial sponsor. It is essential to check with the health plan representative to confirm what costs will be covered before enrolling a patient in a clinical trial. 

If You Can’t Get into a Clinical Trial 

When clinical trial enrollment isn’t possible, other options for accessing experimental treatments include the FDA’s Expanded Access program, also known as Compassionate Use. This program allows patients with serious or life-threatening conditions to access investigational treatments outside of clinical trials. To be eligible, the patient must have no comparable or satisfactory alternative treatment options, and the probable risk from the investigational product should not be greater than the probable risk from the condition. 

Doctors can help patients apply for Expanded Access by coordinating with the manufacturer and submitting the necessary documentation to the FDA. It is important to note that patients may need to pay for the product, though sometimes manufacturers provide it at no cost. 

Your Action Plan 

Approaching the subject of experimental treatments and clinical trials requires careful planning and execution. When an insurer denies a claim for a standard treatment by calling it experimental, it is crucial to gather comprehensive evidence and submit a detailed appeal. If the appeal process is unsuccessful, exploring clinical trials as an alternative treatment option is advisable. 

Doctors should consult with their peers and use reliable online databases to identify relevant clinical trials for their patients. Evaluating trials based on eligibility, objectives, location, and duration is essential. Once a promising trial is identified, contacting the trial team for detailed information and assessing the potential risks and benefits is crucial. 

Understanding the financial implications of participating in a clinical trial is also important. Confirming what costs the insurer will cover and clarifying with the trial sponsor which specific costs will be covered is essential. If trial participation isn’t feasible, doctors should consider the FDA’s Expanded Access program to help patients access investigational treatments. 

Disclaimer 

This article is intended for informational purposes only and does not constitute medical, legal, or financial advice. The information provided herein is based on current laws and regulations as of the date of publication and may not be applicable in all jurisdictions. Readers should consult with their healthcare providers, legal advisors, and insurance representatives for specific guidance related to their individual circumstances. The authors and publishers of this article are not responsible for any errors or omissions or any outcomes resulting from the use of this information.